TY  - RPRT
TI  - A SARS-CoV-2 vaccine designed for manufacturability results in unexpected potency and non-waning humoral response
AU  - Campbell, E.
AU  - Dobkin, J.
AU  - Osorio, L.
AU  - Ramasamy, S.
AU  - Kumar, R.
AU  - SantAngelo, D. B.
AU  - Subbian, S.
AU  - Denzin, L. K.
AU  - Anderson, S.
PY  - 2023
DO  - 10.1101/2023.02.06.527376
UR  - https://www.biorxiv.org/content/10.1101/2023.02.06.527376v1
ID  - 10.1101/2023.02.06.527376
ER  -